MedX Health Corp.'s next confirmed earnings release is scheduled for December 2, 2026.
| Earnings Date | 12/2/2026 |
As of June 30, 2026, MedX Health Corp. has 327.93M shares outstanding.
| Shares Outstanding | 327.93M |
As of June 30, 2026, MedX Health Corp. maintains a current ratio of 0.02, meaning it holds 0.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -81.23, indicating conservative leverage, while an interest coverage ratio of -2.52 demonstrates limited ability to service its debt obligations.
| Current Ratio | 0.02 |
| Quick Ratio | 0.01 |
| Debt / Equity | -81.23 |
| Debt / EBITDA | -2.06 |
| Interest Coverage | -2.52 |
These figures cover the twelve months ended June 30, 2026. Return on assets (ROA) is negative at -837.92, reflecting losses generated across the asset base. Inventory turnover of 1.40 indicates how many times MedX Health Corp. sells and replaces its inventory over a year, a key working capital efficiency ratio.
| Return on Assets (ROA) | -837.92 |
| Inventory Turnover | 1.40 |
As of the close on November 11, 2026, MedX Health Corp.'s stock has gained approximately 10.00% over the past 52 weeks. The 50-day moving average sits at 0.04, while the 200-day moving average is 0.09.
| 52-Week Price Change | 10.00% |
| 50-Day Moving Average | 0.04 |
| 200-Day Moving Average | 0.09 |
Over the twelve months ended June 30, 2026, MedX Health Corp. generated 401,485.33 in revenue and converted that into -4.36M in net income, yielding earnings per share of -0.01. EBITDA reached -2.97M, while operating income came in at -3.01M.
| Revenue | 401,485.33 |
| Gross Profit | 132,861.94 |
| Operating Income | -3.01M |
| Pretax Income | -4.36M |
| Net Income | -4.36M |
| EBITDA | -2.97M |
| EBIT | -3.01M |
| Earnings Per Share (EPS) | -0.01 |
As of June 30, 2026, MedX Health Corp. holds 13,804.86 in cash and equivalents against 6.12M in total debt, resulting in a net debt position of 5.92M. Total book value stands at -7.54M, with working capital of -6.54M providing operational flexibility.
| Cash & Cash Equivalents | 13,804.86 |
| Total Debt | 6.12M |
| Net Debt | 5.92M |
| Equity (Book Value) | -7.54M |
| Book Value Per Share | -0.02 |
| Working Capital | -6.54M |
MedX Health Corp. produced -2.66M in operating cash flow over the twelve months ended June 30, 2026. After subtracting - - in capital expenditures, free cash flow totaled -2.66M - equivalent to -0.01 per share.
| Operating Cash Flow | -2.66M |
| Free Cash Flow | -2.66M |
| FCF Per Share | -0.01 |
Over the twelve months ended June 30, 2026, MedX Health Corp. posted a gross margin of 33.09, reflecting its pricing power and cost economics. The operating margin of -750.44 and net profit margin of -1,085.95 provide insight into operational efficiency.
| Gross Margin | 33.09 |
| Operating Margin | -750.44 |
| Pretax Margin | -1,085.95 |
| Profit Margin | -1,085.95 |
| EBITDA Margin | -739.80 |
Already premium?